West Pharmaceutical Services (WST) to Release Quarterly Earnings on Thursday

West Pharmaceutical Services (NYSE:WST - Get Free Report) is projected to issue its quarterly earnings data before the market opens on Thursday, April 24th. Analysts expect the company to announce earnings of $1.30 per share and revenue of $685.24 million for the quarter. West Pharmaceutical Services has set its FY 2025 guidance at 6.000-6.200 EPS.Parties that wish to listen to the company's conference call can do so using this link.

West Pharmaceutical Services (NYSE:WST - Get Free Report) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $1.82 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.75 by $0.07. The business had revenue of $748.80 million during the quarter, compared to analysts' expectations of $739.59 million. West Pharmaceutical Services had a return on equity of 18.60% and a net margin of 17.03%. On average, analysts expect West Pharmaceutical Services to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.

West Pharmaceutical Services Trading Down 3.5 %

Shares of NYSE:WST traded down $7.35 during mid-day trading on Friday, reaching $201.78. 1,684,568 shares of the company's stock were exchanged, compared to its average volume of 700,425. The firm has a market capitalization of $14.59 billion, a price-to-earnings ratio of 30.16, a PEG ratio of 6.74 and a beta of 1.22. West Pharmaceutical Services has a twelve month low of $187.43 and a twelve month high of $394.42. The business's fifty day moving average price is $219.89 and its 200-day moving average price is $286.61. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.23 and a current ratio of 2.79.

West Pharmaceutical Services Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 7th. Stockholders of record on Wednesday, April 30th will be paid a $0.21 dividend. The ex-dividend date of this dividend is Wednesday, April 30th. This represents a $0.84 annualized dividend and a dividend yield of 0.42%. West Pharmaceutical Services's payout ratio is 12.56%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. StockNews.com downgraded West Pharmaceutical Services from a "buy" rating to a "hold" rating in a report on Thursday, February 27th. Citigroup began coverage on West Pharmaceutical Services in a research note on Wednesday, January 8th. They issued a "buy" rating and a $400.00 price objective for the company. Evercore ISI began coverage on West Pharmaceutical Services in a report on Tuesday, March 18th. They issued an "outperform" rating and a $275.00 target price on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of West Pharmaceutical Services from a "hold" rating to a "buy" rating and set a $250.00 price objective on the stock in a report on Friday, February 14th. Finally, KeyCorp decreased their target price on shares of West Pharmaceutical Services from $470.00 to $325.00 and set an "overweight" rating for the company in a research report on Friday, February 14th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, West Pharmaceutical Services has a consensus rating of "Moderate Buy" and an average price target of $332.50.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.